NCT03821506 ROOM-LIGHT: Effect of a Dynamic Lighting System in Depressed Inpatients Status COMPLETED Phase NA
NCT03811860 Lithium Therapeutic Drug Monitoring; Once Daily Vs Twice Daily Dosing and the Impact of Kidney Function Status UNKNOWN Phase NA
NCT03804619 Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder Status WITHDRAWN Phase NA
NCT03795688 The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health Status COMPLETED Phase N/A
NCT03790085 Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals Status UNKNOWN Phase EARLY_PHASE1
NCT03787290 Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder Status SUSPENDED Phase PHASE2
NCT03786731 A Transdiagnostic Sleep and Circadian Treatment for Major Depressive Disorder Status UNKNOWN Phase NA
NCT03785652 Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE1
NCT03780881 EXperimental Paradigm to Investigate Expectation Change in Depression 4 Status COMPLETED Phase NA
NCT03779789 Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment Status COMPLETED Phase PHASE4
NCT03774641 A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women Status COMPLETED Phase N/A
NCT03771664 A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia Status TERMINATED Phase PHASE3
NCT03769350 Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), Withdrawn Status WITHDRAWN Phase NA
NCT03766867 Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression Status COMPLETED Phase PHASE2
NCT03761030 L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults Status TERMINATED Phase PHASE4
NCT03749629 Comparative Effectiveness of Pharmacogenomics for Treatment of Depression Status COMPLETED Phase NA
NCT03748446 Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder Status RECRUITING Phase EARLY_PHASE1